Key result
Diabetic microangiopathy and macroangiopathy were associated with significantly elevated serum levels of soluble adhesion molecules compared to patients with no complications.
Why the study?
Are serum concentrations of soluble adhesion molecules associated with diabetic microangiopathy and macroangiopathy in patients with Type 2 diabetes?
Observational (n=296)
Are serum concentrations of soluble adhesion molecules associated with diabetic microangiopathy and macroangiopathy in patients with Type 2 diabetes?
Soluble adhesion molecules are elevated in diabetic micro- and macroangiopathy, with potentially greater relative contributions in microangiopathy.
Answers are grounded in this paper and cite their sources.
Highlights potential biomarker role in diabetic vasculopathy; hypothesis-generating and should not yet change practice.
AIMS: To clarify the correlation between serum concentrations of soluble adhesion molecules and diabetic microangiopathy or macroangiopathy in patients with Type 2 diabetes. METHODS: Patients with diabetic retinopathy and intima-media thickness of common carotid artery (CCA-IMT) < 1.1 mm were classified as the microangiopathy group (n = 62). Patients with CCA-IMT > or = 1.1 mm and without retinopathy were classified as the macroangiopathy group (n = 95). Patients with CCA-IMT < 0.9 mm and without retinopathy were assigned to the no complications group (n = 139). Clinical characteristics and soluble intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and E-selectin levels were compared between the groups. RESULTS: Patients with microangiopathy had a significantly longer duration of diabetes, were hypertensive and more likely to have a positive family history of diabetes than the control group. Patients with macroangiopathy were more likely to be smokers, hypertensive, and have a family history of hypertension. Soluble ICAM-1, VCAM-1, and E-selectin levels were significantly higher in the microangiopathy group than in the control group. Soluble VCAM-1 and E-selectin levels, but not ICAM-1 levels, were significantly elevated in the macroangiopathy group. These results were unchanged after adjustment for age, sex, duration of diabetes, blood pressure, HbA1c, HDL-cholesterol, and smoking status. CONCLUSIONS: Our results suggest that soluble adhesion molecules are related to both diabetic micro- and macroangiopathy. The relative contributions of adhesion molecules may be greater in the former than latter patients with Type 2 diabetes.
No takes yet. Share an insight, caveat, or question.
Matsumoto et al. (2002) conducted an observational in Type 2 diabetes (n=296). Diabetic microangiopathy and macroangiopathy vs. No complications (CCA-IMT < 0.9 mm without retinopathy) was evaluated on Serum concentrations of soluble adhesion molecules (ICAM-1, VCAM-1, and E-selectin). Diabetic microangiopathy and macroangiopathy were associated with significantly elevated serum levels of soluble adhesion molecules compared to patients with no complications.
Synapse has enriched 10 related papers. Consider them for comparative context: